Overview
Stanislas Blein practices practicing medicine in Lausanne, Switzerland.
Blein is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Relapsed Refractory Multiple Myeloma (RRMM) and Multiple Myeloma.
They are actively involved in clinical research, co-authoring 8 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Stanislas Blein
Is Stanislas Blein a top-rated expert for Relapsed Refractory Multiple Myeloma (RRMM)?
MediFind is an objective health platform that identifies experts based on real-world data. Stanislas Blein is classified as an Advanced expert for Relapsed Refractory Multiple Myeloma (RRMM), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Stanislas Blein participate in research or clinical trials?
Yes. Stanislas Blein has published 8 articles and abstracts on conditions like Relapsed Refractory Multiple Myeloma (RRMM). You can view a list of Stanislas Blein's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Relapsed Refractory Multiple Myeloma (RRMM)
- Experienced
- Multiple MyelomaBlein isExperienced. Learn about Multiple Myeloma.